N4 Pharma (LON:N4P) Shares Up 4.5% – Here’s What Happened

N4 Pharma Plc (LON:N4P)’s stock price traded up 4.5% on Monday . The company traded as high as GBX 0.70 ($0.01) and last traded at GBX 0.70 ($0.01). 5,446,512 shares traded hands during trading, an increase of 61% from the average session volume of 3,377,207 shares. The stock had previously closed at GBX 0.67 ($0.01).

N4 Pharma Price Performance

The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 22.73. The stock has a market cap of £2.91 million, a PE ratio of -55.00 and a beta of -0.37. The stock’s 50-day moving average is GBX 0.62 and its two-hundred day moving average is GBX 0.59.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.